2000
DOI: 10.1159/000007283
|View full text |Cite
|
Sign up to set email alerts
|

Systemic Infections with <i>Candida</i> sp. and <i>Aspergillus</i> sp. in Immunocompromised Patients with Hematological Malignancies: Current Serological and Molecular Diagnostic Methods

Abstract: Within recent years, novel serological and molecular methods have been developed to improve the early diagnosis of invasive fungal infections especially in patients with malignant hematological diseases being at highest risk of developing these life-threatening infections. Early diagnosis is essential for adequate therapeutic management, which, however, often remains difficult since the diagnostic tools clinically used either lack specificity or sensitivity, or both at worst. The clinical value, the advantages… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2000
2000
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(4 citation statements)
references
References 32 publications
0
4
0
Order By: Relevance
“…15 Recently, the enzyme-linked immunosorbent assay (ELISA) for galactomannan detection has been introduced and found to be a sensitive marker for follow-up of the clinical outcome of invasive aspergillosis, although much less specific for an initial diagnosis of the disseminated disease. 15,17 Treatment of aspergillosis requires a high index of suspicion, rapid diagnosis and prompt institution of antifungal therapy. The treatment of choice is still amphotericin B, [1][2][3][4]11,18 although some recent studies refer to itraconazole and caspofungin as similarly effective in the therapy of disseminated disease.…”
Section: Discussionmentioning
confidence: 99%
“…15 Recently, the enzyme-linked immunosorbent assay (ELISA) for galactomannan detection has been introduced and found to be a sensitive marker for follow-up of the clinical outcome of invasive aspergillosis, although much less specific for an initial diagnosis of the disseminated disease. 15,17 Treatment of aspergillosis requires a high index of suspicion, rapid diagnosis and prompt institution of antifungal therapy. The treatment of choice is still amphotericin B, [1][2][3][4]11,18 although some recent studies refer to itraconazole and caspofungin as similarly effective in the therapy of disseminated disease.…”
Section: Discussionmentioning
confidence: 99%
“…The detection of anti‐ Aspergillus antibodies has been found to be unhelpful in neutropenic patients, and positive Aspergillus antigen (galactomannan) tests were obtained in only 12% of patients with invasive disease in one study 15 . Recently, the enzyme‐linked immunosorbent assay (ELISA) for galactomannan detection has been introduced and found to be a sensitive marker for follow‐up of the clinical outcome of invasive aspergillosis, although much less specific for an initial diagnosis of the disseminated disease 15,17 . Treatment of aspergillosis requires a high index of suspicion, rapid diagnosis and prompt institution of antifungal therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Consequently, due to the long-term use of these antifungal agents/antibiotics, the susceptible candidal species die while the resistant species tend to proliferate themselves, causing serious problems for the hosts. 6 In an effort to increase the range of antibacterial drugs from plant resources, Capparis decidua commonly called as Kirir belongs to the family Capparaceae has been selected. Traditionally, it is used to cure many diseases.…”
Section: Introductionmentioning
confidence: 99%